Drug-related Symptoms and Managing Them with Benlysta
Benlysta (belimumab) is a medication used to treat systemic lupus erythematosus (SLE), a chronic autoimmune disease. While it can be effective in managing symptoms, it's essential to be aware of its potential side effects and precautions.
Common side effects of Benlysta include nausea, diarrhea, insomnia, fever, and skin reactions at the injection site. However, less common side effects can also occur.
One such less frequent side effect is the increased risk of infections, particularly when taking higher doses or for extended periods. This includes rare infections from exposure to products containing live organisms.
Another less common side effect is allergic reactions. While these are rare, monitoring for such reactions is crucial. Symptoms can range from mild, such as skin rash or itching, to more severe, including swelling under the skin, difficulty breathing, or swelling of the mouth, tongue, or throat.
Given its mechanism of action, Benlysta can lead to immune system suppression, potentially increasing susceptibility to infections.
If you have cancer or a history of cancer, it's important to inform your doctor before starting Benlysta. While it's not known whether Benlysta may increase your risk of cancer, your doctor may monitor your condition more often during treatment.
If you have a history of depression or another mental health condition, you may have a higher risk of developing depression while taking Benlysta. It's possible for Benlysta to cause depression, which can lead to suicidal thoughts or behaviors. In this case, your doctor may monitor your mental health more often during treatment.
If you become pregnant during treatment, it's crucial to inform your doctor right away. They may recommend that you stop treatment with Benlysta or enroll in Benlysta's pregnancy registry.
It's also important to note that Benlysta is not recommended for children with active lupus nephritis. However, subcutaneous injections of Benlysta are approved for children ages 5 years and older with SLE.
If you experience any unusual symptoms while taking Benlysta, it's advisable to report them to your healthcare provider.
If you or someone you know is in crisis and considering suicide or self-harm, please seek support. In the US, you can call or text the 988 Lifeline at 988 or chat at 988lifeline.org, text HOME to the Crisis Text Line at 741741, call 911 or your local emergency services number if you feel safe to do so.
In conclusion, while Benlysta can be an effective treatment for SLE, it's crucial to be aware of its potential side effects and precautions. Always consult with your healthcare provider if you have any concerns or questions about your treatment.
